Enhancing the Response to Cardiac Resynchronization Therapy Is It Time to Individualize the Left Ventricular Pacing Site?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. by Singh, Jagmeet P. & Abraham, William T.
E
R
R
I
t
J
W
B
C
s
s
a
c
c
t
b
C
s
p
t
p
r
h
i
c
e
f
b
i
w
C
a
m
g
h
C
p
v
i
n
a
I
t
d
i
L
d
S
(
o
t
o
t
g
1
c
v
n
T
w
p
t
a
b
s
p
s
a
S
f
i
s
s
g
i
p
l
h
p
t
a
p
t
h
b
w
s
*
v
A
S
O
Journal of the American College of Cardiology Vol. 55, No. 6, 2010
© 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2009.10.017EDITORIAL COMMENT
nhancing the
esponse to Cardiac
esynchronization Therapy
s It Time to Individualize
he Left Ventricular Pacing Site?*
agmeet P. Singh, MD, PHD,†
illiam T. Abraham, MD‡
oston, Massachusetts; and Columbus, Ohio
ardiac resynchronization therapy (CRT) has gained wide-
pread acceptance as a safe and efficacious therapeutic
trategy for New York Heart Association functional class III
nd ambulatory class IV chronic heart failure (CHF) asso-
iated with a wide QRS complex and ventricular dyssyn-
hrony. Several prospective, randomized studies have shown
hat CRT is associated with significant improvement in
oth hemodynamics and functional status of patients with
HF (1,2). CRT seems to exert its physiological impact by
ynchronizing ventricular contraction through pacing leads
ositioned along the right and left ventricular (LV) walls of
he heart, resulting in improved pumping efficiency, im-
See page 566
roved LV filling, and a reduction in the severity of mitral
egurgitation. Over time, there is positive remodeling of the
eart with a reduction in LV volume and an improvement
n the ejection fraction (3). This in turn results in long-term
linical benefits such as improved quality of life, increased
xercise capacity, reduction in hospitalizations for heart
ailure, and improved overall survival. Despite its proven
enefits, there remain several unresolved issues, with the most
mportant being that as many as one-third of patients treated
ith CRT do not derive any demonstrable benefit (2).
Given the high prevalence, morbidity, and mortality of
HF and the substantial cost to society, both from CHF as
disease and from CRT as a therapy, the importance of
aximizing the response of all patients to CRT is obviously
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Massachusetts General Hospital Heart Center, Harvard Medicalw
chool, Boston, Massachusetts; and the ‡Division of Cardiovascular Medicine, The
hio State University Medical Center, Columbus, Ohio.reat. Using baseline predictors of responsiveness to CRT is
elpful, but not definitive. Selecting the “right” patient for
RT but stimulating the “wrong” site remains an important
otential cause of nonresponsiveness to CRT. Interpatient
ariability in the LV electrical activation sequence (4),
nconsistency of the coronary venous anatomy (5), and the
eed for acceptable pacing parameters may preclude the
ttainment of an optimal LV pacing site in some patients.
ntraprocedural aspects of lead placement such as: 1) ana-
omical lead position; 2) proximity to scar tissue; 3) concor-
ance with the segment of mechanical dyssynchrony; 4)
mpact on mitral regurgitation; and 5) relationship to the
V activation sequence (6) may play an important role in
etermining the response to CRT.
tudy summary. In this issue of the Journal, Derval et al.
7) show in 35 patients with nonischemic dilated cardiomy-
pathy that not only is the LV pacing site a determinant of
he hemodynamic response but that there is a great degree
f variability in the most optimal pacing site, even within
his relatively homogeneous group of patients. The investi-
ators randomly tested 11 predetermined LV pacing sites,
0 of which were endocardial via transseptal access and 1
onventional coronary sinus (CS) site. The basal and mid-
entricular segments of 4 different walls of the left ventricle,
amely, septal, anterior, lateral, and inferior, were tested.
he authors showed that an individually-based approach
ith systematic testing revealed a variety of optimal LV
acing locations that were quite different from the conven-
ional CS pacing, lateral wall pacing, and the echo-guided
pproaches (7). This report highlights a commonly believed
ut not adequately proved notion that with CRT a “one-
ize-fits-all strategy” does not work. In fact, this study
rovides evidence that the best LV pacing site is not only
pecific to the individual, but also that it cannot be defined
priori (7).
tudy-related issues. Although this report brings to the
orefront the complexity of lead location and CRT response,
t has some methodological concerns that should be con-
idered before extrapolating the results to the real-world
ituation. For the site-specific pacing protocol, the investi-
ators incorporated the entire lateral wall (which would
nclude the lateral and posterolateral walls and possibly a
art of the anterolateral wall) as 1 site. The free wall of the
eft ventricle is a very large territory, and variable responses
ave been shown, even in the same patient, between
osterolateral and lateral wall stimulation. Consequently, in
he dilated heart, where distances are even more exagger-
ted, specific testing along the anterolateral, lateral, and
osterolateral walls may have been more meaningful. Fur-
hermore, the clinical applicability of these results would
ave been enhanced if more than 1 CS branch site from the
ase and mid-ventricular regions (vs. endocardial pacing)
ere tested. Also, endocardial apical pacing (as used in this
tudy) can have a very different hemodynamic response
hen compared with epicardial stimulation from the apical
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February 9, 2010:576–8 Individualize the LV Pacing Site?egment on the anterolateral, mid-lateral, and posterolateral
alls. This would have been important to test because many
imes, using the transvenous approach, implanters will
dvance the LV lead through the coronary venous tree
istally toward the apical segment for more stability. Addi-
ionally, the durability of the acute hemodynamic response
nd its role as a predictor of long-term clinical outcome are
ncertain. Although previous work suggested that the post-
mplantation LV dP/dT may predict the clinical response to
RT (8), this is as yet unproven and one can speculate that
here could be substrate-dependent differences between
cute hemodynamic and long-term clinical responses to
RT. For example, in a scar-laden heart, a good acute
emodynamic response may not be able to predict the stress,
train, scar-pacing site interactions and myocardial remod-
ling over a period of time. It could be hypothesized that in
ertain situations, a less effective acute hemodynamic re-
ponse with better remodeling forces may be preferable.
hus, although the findings of Derval et al. (7) are impor-
ant, they must now be evaluated in the long-term clinical
etting before a recommendation can be made to pursue
uch an LV optimization strategy in all patients.
ite-specific pacing. It is interesting to note that even in
his relatively homogeneous population of nonischemic
HF patients, 6% of patients had minimal improvement
i.e., 0% to 10% change in dP/dTmax), whereas another 9%
ad worsening with pacing at the best (individually ap-
roached) site. The lack of adequate response to endocardial
ateral wall pacing (dP/dTmax change of 10%) in 42% of
he subjects suggests that there is more to site-specific
acing than targeting an anatomical region (7). Because the
oncept of CRT revolves around resynchronization of the
eart, pacing and synchronizing the site of latest activation
ake sense. However, the absence of an adequate response
o this targeted strategy (in 17%) brings into question the
dequacy of the echocardiographic strategy used for dem-
nstrating the latest activated wall in this report (9). Derval
t al. (7) did not look at the extent of electrical delay (via the
ensed signal off the LV lead) at the paced sites, thereby
issing an opportunity to answer a very important question:
s targeting the site of electrical delay superior to pacing over
he latest contracting site? This is particularly important
ecause previous work showed that pacing from a site with
ore delayed electrical activation is associated with a
eneficial acute hemodynamic response and an improved
ong-term outcome (6). Although the authors conclude that
onventional pacing from the CS is rarely optimal, it must
e emphasized that only 1 CS site was tested (7). Also, the
efinement of CS delivery sheaths, better angiographic
trategies, and an array of LV leads (with multiple electrodes
nd many shapes) with fixation strategies have created a
ituation in which many more CS sites are accessible.
entricular activation sequence and response. Different
evels of intraventricular conduction defects and varied
ombinations of right or left bundle branch and fascicular
locks make the LV activation pattern unpredictable (10). bypically, left bundle branch block is associated with a
-shaped activation pattern that travels via the apex, with
he lateral and posterolateral portions of the left ventricle
eing activated last (4). This spread of electrical activity
orrelates well with mechanical activation and has been the
ain determinant of the conventional implantation ap-
roach of positioning the LV leads in a lateral location.
here remains, however, a high level of heterogeneity in the
epolarization wave front of the left ventricle and a wide
ariance in the area of latest LV activation. To add to this
omplexity, there is evidence that patients with ischemic
eart disease have even a greater degree of inhomogeneity in
he ventricular activation pattern. The presence of a scar
ay shift the region of latest activation to the edge of the
car, and the exit of the LV paced impulse from a bordering
rea can be rendered erratic and considerably delayed (11).
ven in the nonischemic heart, LV activation can be
nfluenced by the spatial conductive properties of the sub-
trate at the site of LV pacing. However, there is evidence
hat the electrical activation pattern is different among
atients with similar left bundle branch configurations,
uggesting that an optimal anatomical site (along the lateral
all) may not be reflective of the most delayed electrome-
hanical site (10). Moreover, in patients receiving pure LV
acing, the overall impact of pacing is affected by the degree
f fusion with the intrinsic activation sequence, which can
e influenced by the length of the atrioventricular delay.
emembering the right ventricular lead. Furthermore,
he pacing mode for this study was DDD LV pacing (7), as
pposed to the real-world scenario, where biventricular
acing is the norm. This is important because right ventric-
lar pacing (in the CRT patient) may induce shifts in the
V electrical and mechanical activation patterns (12). This
ould even further increase the variability of the optimal LV
acing site and alter pre-procedural assessments regarding
argeted placement over the most delayed segment. Even in
he setting of endocardial LV stimulation, the fact that
entricular depolarization during biventricular pacing rep-
esents fusion of right ventricular and LV pacing (and often
f intrinsic conduction) emphasizes the need to consider
ptimizing the interlead relationship to maximize ventricu-
ar resynchronization. Even increased radiographic separa-
ion between the right ventricular and LV pacing electrodes
s a determinant of the acute hemodynamic response to
RT (13).
We know from a number of studies that that the optimal
trioventricular delay needs to be individualized (14) to
arner the most optimal LV filling pattern as well as take
dvantage of the innate depolarization wave front to en-
ance fusion, synchrony, and consequently the mechanoen-
rgetic efficiency of the heart (15). It is quite possible that
he hemodynamic impact of each site could be variable with
urther alterations of the atrioventricular delay, bringing
nto question the reliability of the best pacing site as shown
y the investigators.
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Individualize the LV Pacing Site? February 9, 2010:576–8The investigators and the patients recruited in the study
eed to be congratulated for engaging in such a rigorous and
engthy protocol. Although this study shows us the high
egree of individual variability for the best pacing site, at the
ame time, it must be emphasized that the evaluation
utlined in the study by Derval et al. (7) is impractical to
dapt to everyday use. The different types of cardiomyopa-
hy, at different stages of progression with variable electrical
nd structural remodeling, pose a challenge to getting the
uperlative LV lead position. Advances in epicardial and
ransseptal LV endocardial approaches may enhance our
bility to test more sites. Even advances in the tools and
echniques associated with the conventional transvenous CS
ased–approaches have increased our access to regions and
ranches that were inaccessible a few years ago. The
essage that we need to individualize our approach is
mportant, but how we do so in a practice-oriented way still
eeds to be defined.
eprint requests and correspondence: Dr. William T. Abraham,
ivision of Cardiovascular Medicine, Ohio State University, 473
est 12th Avenue, Room 110P DHLRI, Columbus, Ohio
3210-1252. E-mail: william.abraham@osumc.edu.
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